IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Cambrex Profits Fall on Low Generic API Sales

10:19 AM MDT | August 18, 2008 | Deepti Ramesh

Cambrex (East Rutherford, NJ) posted second-quarter net profits down 19%, to $1.8 million, on sales up by 5%, to $66.2 million. Sales of generic active pharmaceutical ingredients (APIs) fell in the quarter but were partially offset by higher custom manufacturing revenues, including higher revenues from controlled substances, Cambrex says. “New laboratories in our Iowa facility were commissioned during the second quarter to support growing demand for highly potent compounds,” says Steven Klosk, president and CEO. The company says its new API finishing...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa